A. Paccagnella

发表

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.

A. Ardizzoni, L. Boni, M. Tiseo, 2007, Journal of the National Cancer Institute.

1064 Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study

L. Crinò, M. Marangolo, V. Adamo, 1995 .

Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.

A. Paccagnella, R. Carnuccio, O. Nascimben, 2004, International journal of radiation oncology, biology, physics.

Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer: A phase II trial

M. Fiorentino, A. Paccagnella, A. Morabito, 1996, Cancer.

Long term results of surgery and chemotherapy in small cell lung cancer.

A. Paccagnella, F. Rea, A. Favaretto, 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

A. Paccagnella, A. Bonetti, L. Tomio, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

CISCA (cisplatin vs. carboplatin) meta-analysis: An individual patient data meta-analysis comparing cisplatin versus carboplatin-based chemotherapy in first-line treatment of advanced non-small cell lung cancer (NSCLC).

A. Ardizzoni, L. Boni, M. Tiseo, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of chemotherapy in locally advanced head and neck squamous cell carcinoma.

A. Paccagnella, E. Cohen, T. Nwizu, 2012, Seminars in radiation oncology.

Elderly Patients with Small Cell Lung Cancer

A. Paccagnella, F. Oniga, R. Biason, 2002, Tumori.

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial

R. Orecchia, A. Paccagnella, C. Casanova, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).

I. Floriani, A. Paccagnella, G. Azzarello, 2014 .

Therapeutic Intensification and Induction Chemotherapy for High-Risk Locally Advanced Squamous Cell Carcinoma

A. Paccagnella, M. Ghi, 2019, Current Treatment Options in Oncology.

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.

G. Scagliotti, F. de Marinis, L. Crinò, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tamoxifen in Disseminated Breast Cancer

A. Paccagnella, G. Palù, E. Ferrazzí, 1977, Tumori.

Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony-stimulating factor

E. Ascari, A. Paccagnella, L. Chieco‐Bianchi, 1993, Annals of Hematology.

Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?

A. Paccagnella, M. Ghi, P. D'Amanzo, 2010, The oncologist.

Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapy

Paolo Carlini, Antonio Mazzei, Francesco Campione, 1999, The Lancet.

Chemotherapy of Lung Cancer

A. Paccagnella, M. Fiorentino, G. Favaretto, 1988 .

A Pilot Study of Concomitant Radiation and Chemotherapy in Patients with Locally Advanced Head and Neck Cancer

A. Paccagnella, V. Chiarion-Sileni, L. Tomio, 1993, American journal of clinical oncology.

Extramedullary plasmacytoma: clinical behaviour and response to treatment.

A. Paccagnella, V. Chiarion-Sileni, A. Favaretto, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Concomitant chemoradiation or RT/cetuximab versus induction TPF followed by chemoradiation or RT/cetuximab in locally advanced head and neck squamous cell carcinoma: A randomized phase III factorial study.

I. Floriani, A. Paccagnella, A. Gava, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response and Toxicity of Cisplatin and 120‐h 5‐Fluorouracil Infusion in Pretreated and Untreated Patients with Advanced Epidermoid Cancer of the Head and Neck

A. Paccagnella, P. Zorat, G. Pappagallo, 1990, American journal of clinical oncology.

Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.

Pierre Blanchard, Gilles Calais, Jean Bourhis, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent radiochemotherapy in high-grade glioma

A. Brandes, P. Zampieri, A. Paccagnella, 1994 .

Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.

A. Paccagnella, M. C. da Mosto, L. Tomio, 2004, Journal of the National Cancer Institute.

Intrapericardial instillation of platin in malignant pericardial effusion

A. Paccagnella, P. Morandi, C. Ghiotto, 1988, Cancer.

Study of the expression and function of the tumour-associated antigen CaMBr1 in small cell lung carcinomas.

S. Ménard, A. Paccagnella, S. Fasolato, 1993, European Journal of Cancer.

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma

A. Paccagnella, S. Monfardini, F. Rea, 2003, Cancer.

Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosis

A. Paccagnella, O. Vinante, E. Biganzoli, 2000, Breast Cancer Research and Treatment.

Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.

A. Paccagnella, L. Tomio, P. Zorat, 1994, Journal of the National Cancer Institute.

5-year prospective results of trimodality treatment for malignant pleural mesothelioma.

A. Paccagnella, V. Pagan, G. Pizzi, 2006, The Journal of cardiovascular surgery.

Ultrarapid high-dose course of prophylactic cranial irradiation in small-cell lung cancer: evaluation of late neurologic morbidity in 16 long-term survivors.

A. Paccagnella, F. Rea, A. Favaretto, 1998, American journal of clinical oncology.

Paclitaxel and carboplatin in combination with gemcitabine: a phase I-II trial in patients with advanced non-small-cell lung cancer. Gruppo Studio Tumori Polmonari Veneto (GSTPV).

G. Ceresoli, A. Paccagnella, E. Villa, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer.

L. Crinò, F. Puglisi, A. Paccagnella, 2010, Breast.

Chemotherapy of invasive thymoma.

A. Paccagnella, P. Morandi, F. Rea, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin, etoposide, and ifosfamide in non‐small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

A. Brandes, A. Paccagnella, V. Chiarion-Sileni, 1990, Cancer.

Peptichemio in pretreated patients with plasmacell neoplasms.

A. Paccagnella, V. Chiarion-Sileni, G. Pappagallo, 1986, European journal of cancer & clinical oncology.

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

G. Ceresoli, V. Chiarion Sileni, A. Paccagnella, 2004, Lung cancer.

Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.

A. Chella, M. Clerici, G. Ceresoli, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck

M. Mazumdar, J. Pignon, J. Bourhis, 2004, Anti-cancer drugs.

Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game.

A. Paccagnella, E. Biganzoli, P. Boracchi, 2002, European journal of cancer.

Treatment of advanced non-small cell lung cancer: chemotherapy with or without cisplatin?

A. Paccagnella, V. Gebbia, F. Oniga, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI – Mel.A.) [ISRCTN75125874]

M. Guida, A. Paccagnella, V. Chiarion-Sileni, 2006, BMC Cancer.

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients

A. Paccagnella, S. Monfardini, A. Favaretto, 2001, Melanoma research.

Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer.

A. Paccagnella, A. Peracchia, C. Tremolada, 1986, Cancer treatment reports.

Serum Copper Level in Non-Hodgkin's Lymphomas

A. Paccagnella, G. Pappagallo, L. Salvagno, 1982, Tumori.

Tamoxifen (JAM) and interferon alfa 2a (IFN) in metastatic melanoma

A. Paccagnella, E. Scelzi, R. Rossi, 1994 .

Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study.

A. Paccagnella, P. Zorat, G. Pappagallo, 1993, European journal of cancer.

Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto

C. Tibaldi, A. Ardizzoni, L. Boni, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin, bleomycin and methotrexate in the treatment of advanced oesophageal cancer.

A. Paccagnella, A. Peracchia, C. Tremolada, 1984, European journal of cancer & clinical oncology.

Second and third responses to the same induction regimen in relapsing patients with multiple myeloma

A. Paccagnella, V. Chiarion-Sileni, D. Casara, 1991, Cancer.

Treatment of multiple myeloma with M-2 protocol and without maintenance therapy.

V. Chiarion Sileni, A. Paccagnella, L. Salvagno, 1983, European journal of cancer & clinical oncology.

Cetuximab/Radiation Therapy (CET + RT) Versus Concomitant Chemoradiation Therapy (cCHT + RT) With or Without Induction Docetaxel/Cisplatin/5Fluorouracil (TPF) in Locally Advanced Head-and-Neck Squamous Cell Carcinoma (LASCCHN) – Preliminary Results on Toxicity of a Randomized, 2x2 Factorial, Phase I

I. Floriani, R. Orecchia, A. Paccagnella, 2012 .

Cetuximab/radiotherapy (CET+RT) versus concomitant chemoradiotherapy (cCHT+RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Preliminary results on toxicity of a randomized, 2x2 factorial, phase II-III study (N

L. Crinò, I. Floriani, A. Paccagnella, 2012 .

A Phase 2-3 Study Comparing Concomitant Chemoradiation Therapy (CRT) Versus Cetuximab/RT (CET/RT) With or Without Induction Docetaxel/Cisplatin/5-Fluorouracil (TPF) in Locally-Advanced Head and Neck Squamous Cell Carcinoma (LASCCHN) – Efficacy Results of the GSTTC Italian Study (NCT01086826)

R. Orecchia, A. Paccagnella, F. Bertoni, 2013 .

P-506 Gemcitabine combined to carboplatin in malignant pleural mesothelioma: a multicentric phase II study

A. Paccagnella, S. Monfardini, F. Rea, 2003 .

Pre-operative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study.

A. Paccagnella, V. Chiarion-Sileni, F. Rea, 1996, European journal of cancer.

Concomitant chemoradiation in locally advanced head and neck squamous cell carcinoma: A literature-based meta-analysis on the platinum concomitant chemotherapy.

I. Floriani, A. Paccagnella, D. Garavaglia, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vindesine in Plasma Cell Tumors

A. Paccagnella, D. Casara, L. Salvagno, 1985, Tumori.

Cisplatin plus Vindesine versus Cisplatin plus VP16 versus Doxorubicin plus Cytoxan in Non-Small-Cell Carcinoma of the Lung. A Randomized Study

A. Brandes, A. Paccagnella, O. Vinante, 1986, Tumori.

Granulocyte‐macrophage colony‐stimulating factor increases dose intensity of chemotherapy in small cell lung cancer: Relationship between clinical results, peripheral blood cell modifications, and bone marrow kinetics

A. Paccagnella, L. Chieco‐Bianchi, A. Riccardi, 1993, Cancer.

82 Treatment of small cell lung cancer (SCLC) in elderly patients (E.P.)

A. Paccagnella, A. Morabito, L. Tomio, 1995 .

[Toxicity of high-dose bleomycin administered by continuous infusion].

A. Paccagnella, E. Ferrazzí, V. Fosser, 1980, Tumori.

Recombinant alpha-interferon and vinblastine in metastatic renal cell carcinoma: efficacy of low doses.

A. Paccagnella, V. Chiarion-Sileni, G. De Sandre, 1988, Seminars in surgical oncology.

Gefitinib (ZD1839) combined with gemcitabine or vinorelbine as single-agent in elderly patients with advanced non-small cell lung cancer (NSCLC).

G. Scagliotti, C. Gridelli, S. Novello, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Urinary Hydroxyproline in Multiple Myeloma: Correlation with Clinical Stages and Bone Disease

A. Paccagnella, L. Salvagno, M. Fiorentino, 1984, Tumori.

Full dose (FD) chemotherapy (CT) plus lenograstim and low dose (LD) CT in elderly SCLC patients. A phase II randomized fonicap-GSTPV study

A. Ardizzoni, L. Boni, A. Paccagnella, 2000 .

Peptichemio in advanced breast cancer: a clinical evaluation in 32 patients.

A. Paccagnella, P. Morandi, L. Salvagno, 1986, Cancer treatment reports.

Peptichemio in pretreated patients with ovarian cancer.

A. Brandes, T. Maggino, A. Paccagnella, 1985, Cancer treatment reports.

Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of malignant pleural mesothelioma (MPM).

A. Ceribelli, L. Spaggiari, A. Paccagnella, 2011, Journal of Clinical Oncology.

Paclitaxel and carboplatin in combination with gemcitabine (PCG): A phase I–II trial in advanced non-small cell lung cancer (NSCLC)

G. Ceresoli, A. Paccagnella, F. Barbieri, 1998 .

A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826).

L. Crinò, I. Floriani, A. Paccagnella, 2013 .

Randomized phase II trial of concomitant CT/RT versus TPF followed by concomitant CT/RT in locally advanced squamous cell carcinoma of the head and neck (LASCCHN).

A. Paccagnella, A. Bonetti, A. Gava, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.